We've been involved in developing and testing vaccines and working with manufacturers to scale-up their production of successful candidates. We launched Australia's first NATA-accredited face mask testing facility, and we're working with water authorities to monitor wastewater for traces of the SARS-CoV-2 virus.
We've studied the structure of the virus, as well as its survivability on different surfaces, and the way different strains respond to vaccines.
Our big data modelling has informed state health dashboards, and we're using new AI techniques to protect the privacy of thousands of Australians being tested every day.
On this page you can access our latest COVID-19 news, feature articles, and multimedia.
Take a deep dive into our research and solutions from science.
Read our COVID-19 media releases
Read comments from our experts
Date | Topic of expert comment |
---|---|
30 Nov |
Omicron coronavirus variant |
07 Jul |
Lambda coronavirus variant |
17 Feb | The TGA’s approval of the Oxford-AstraZeneca vaccine |
08 Jan |
The UK COVID-19 strain and vaccines in Australia |
Date | Topic of expert comment |
---|---|
03 Dec |
Pfizer-BioNTech COVID-19 vaccine authorised in the UK |
24 Nov | Oxford and AstraZeneca vaccine preliminary Phase III data |
09 Sept |
Oxford-AstraZeneca candidate |
19 Aug | CSIRO welcomes vaccine agreement with AstraZeneca-Oxford University |
19 Aug |
Australian Government’s vaccine agreement |
21 Jul |
Oxford vaccine candidate |
12 May | ‘D164G’ mutation of SARS-CoV-2, the virus that causes COVID-19 |
06 Apr |
COVID-19 |
Our experts
Media Contacts
Mr Chris Chelvan
Communication Manager (CORPORATE AFFAIRS)
Ms Helen Beringen
Communication Manager (Corporate Affairs)